Maurizio Battaglia Parodi, Pierluigi Iacono* and Stefano Da Pozzo Pages 1201 - 1207 ( 7 )
The therapeutic approach based on anti-vascular endothelial growth factor (anti-VEGF) molecules can be used to treat two important complications of retinal dystrophies: choroidal neovascularization and macular edema. The macular involvement in retinal dystrophies can lead to further visual deterioration in patients at a young age and already affected by functional limitations. The study reports the effect of anti-VEGF treatment in several subforms of retinal dystrophies, critically discussing advantages and limitations.
Choroidal neovascularization, macular edema retinitis pigmentosa, best vitelliform macular dystrophy, stargardt disease, pattern dystrophy, anti-VEGF.
Department of Ophthalmology, University Vita-Salute San Raffaele, Milan, IRCCS-Fondazione Bietti, Rome, TSRetina, Trieste